Saatja: "Anneli Kolgo-Makki" <
[email protected]>
Saaja: "'RA võltsing'" <
[email protected]>, "Terviseamet" <
[email protected]>
Teema: FW: Intelligence package on counterfeit Ozempic and related products (For Estonia)
Kuupäev: 2025-01-27 12:18
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu
saatja korral palume linke ja faile mitte avada.
Tere,
Saadan Novo Nordiski poolt välja töötatud infopaketi Ozempicu (ja seotud
toodete) kohta teadmiseks ja vajadusel ametite sees edasi jagamiseks,
Kui Eestil on antud teemas mingit infot või juhtumeid, palutakse seda
jagada ka Interpoliga-
Tervitan
Anneli Kolgo-Makki
Ametiabi grupp
Rahvusvahelise ametiabi keskus
Rahvusvahelise operatiivinfo büroo
Piirivalveosakond
Politsei- ja Piirivalveamet
Tööstuse 52, 10416 Tallinn
Tel 612 3797 (73797)
*** AMETIALASEKS KASUTAMISEKS *** Selles e-kirjas sisalduv teave (kaasa
arvatud manused) on mõeldud ametialaseks kasutamiseks ning seda võivad
kasutada vaid e-kirja adressaadid. E-kirjas sisalduvat teavet ei tohi ilma
saatja selgelt väljendatud loata edasi saata ega mistahes viisil
kõrvalistele isikutele avaldada. Juhul, kui Te olete saanud käesoleva
e-kirja eksituse tõttu, teavitage sellest koheselt saatjat ning kustutage
e-kiri oma arvutist. This e-mail and any attachments may contain
confidential and privileged information. If you are not the intended
recipient, please notify the sender immediately by return e-mail, delete
this e-mail and destroy any copies. Any dissemination or use of this
information by a person other than the intended recipient is unauthorized
and may be illegal
From: NG Perry <
[email protected]>
Sent: Monday, January 27, 2025 7:17 AM
To: NCB Tallinn <
[email protected]>
Cc: OEC-CNET-IGGH <
[email protected]>
Subject: Intelligence package on counterfeit Ozempic and related products
(For Estonia)
FROM : IPSG
OEC/CNET/IGGH
Your ref: New
Our ref: 2025/117/OEC/CNET/IGGH/PHPC/PNG
Dear NCB colleagues,
We hope our email finds you well.
In the framework of Operation Pangea XVII and following up from our alerts
regarding the increasing trends of counterfeit Ozempic related products
globally, we would like to provide you with the attached intelligence
package (for Estonia) prepared by the brand owner (Novo Nordisk).
We kindly request that you disseminate to the relevant national agency for
their monitoring of the situation.
Please do not hesitate to contact us should you have any further
intelligence or cases for INTERPOL to support your investigations.
We look forward to your acknowledgement of this message.
Thank you.
Best regards,
……………………………………………
Perry NG
Criminal Intelligence Officer
Criminal Networks
Public Health and Pharmaceutical Crime
INTERPOL Global Complex for Innovation
18 Napier Road, Singapore 258510
Office Phone: +65 6550 3641
[email protected] <mailto:
[email protected]>
<http://www.interpol.int/> www.interpol.int
Background
Who is Novo Nordisk? What? Why?
Novo Nordisk is a Danish pharmaceutical Attention: Our products have gained world-wide Patient safety: Failure to comply with label or
company specialized in diabetes and attention mainly due to weight-loss effects. instruction may cause safety concerns
obesity.
Counterfeit: This has lead to a surge of counterfeit Dangerous: Counterfeit may cause patient harm
products.
Low quality Failure to observe cold-chain or
storage requirements may cause patient harm
Prescription Drugs Cold Chain
ONLY (2-8 °C)
At-risk Products
Wegovy® is approved for Norditropin® is a growth
Ozempic® is approved for Rybelsus is approved for
treatment of obesity. It is hormone approved for
treatment of type 2 diabetes. treatment of type 2 diabetes.
injected once weekly. treatment of growth
It is injected once weekly. It is taken as a tablet daily.
disorders.
How to detect counterfeit
products?
Keep these 3 things in mind:
1. The Sales channel
The counterfeits are found on both physical
and online channels
• Our products should only be sold in
legitimate channels.
Quality
2. Quality & Origin &
The products require professional distribution Origin
and cold chain networks.
• Our products are only produced by certain
factories
Contact
3. Contact Novo Nordisk Illicit Novo Nordisk
Sales Channels
If you have suspicions that counterfeit
products are making it to your market, please
contact Novo Nordisk.
1. The sales channels
WHAT is it about?
Sales of semaglutide is increasing online and offline.
Sales Sources • Online sales: E-commerce platforms, social media
(influencers and illegal sellers) and fake websites
• Offline sales: Pharmacies, gyms clubs
Illicit HOW to manage it?
Sales channels For online sales:
• Be aware on social media (TikTok, X (Ex-Twitter), Facebook…)
• The fake advertisements redirect to fraudulent websites
• Notify us and will take care of the website shutdown
For offline sales:
• In any case of suspicious NN product sales, contact us.
Example Example
Ozempic sells online Ozempic Packaging labelled ”Bayer” found in a gym
2. Quality & Origin ORIGIN of the product
Our products are only manufactured at the listed sites here
• It is counterfeit if products are claimed manufactured
elsewhere
Check product Trends:
quality! • Counterfeit Rybelsus from China
• Counterfeit Ozempic from Turkey (on the rise)
Quality VERIFICATION of packaging
& • Check the dates
Origin • Check the batch number below the dates
• If the batch number is in this list, be suspicious
• Check the general packaging (Novo Nordisk logo, spelling
errors, quality of openings…)
Example Example Example
Fake batch number Incorrect packaging (wrong logo and design) Spelling errors on packaging
3. Contact Novo Nordisk
Suspicion?
We’re available If you have suspicions that counterfeit products are making it to
24/7! your market, please contact the people below or directly Global
Security
Contact
Novo Nordisk CONTACT PERSONS:
Anne DEVAUD Stephen YARDLEY
Head Global Product Security (Global) Regional Security Advisor (EMEA)
[email protected] [email protected]
Jim HENDERSON Renata PEREIRA
Director Risk Management (US) Regional Security Advisor (LATAM)
[email protected] [email protected]
Benedict CHEN Maria Magdalena Korzycka
Regional Security Advisor (APAC) Global Product Security Coordinator
[email protected] [email protected]
8
8
Our
Production
Facilities
Denmark Brazil Iran
Bagsværd, Kalundborg, Hillerød, Monte Claros Tehran
Gentofte, Værløse, Måløv Company: Novo Nordisk Brazil Company: NN Pars (PSJ)
Company: Novo Nordisk Denmark / Our at-risk products are all manufactured
Novo Nordisk A/S USA Algeria from one of these sites.
Clayton, Durham, New Blida, Tizi Ouzou • Any product packaging claiming to be
France Hampshire Company: Aldaph SPA manufactured elsewhere is counterfeit
Chartres Company: Novo Nordisk Inc. /
Company: NN France Production Novo Nordisk USA (Clayt.) Russia If you see a company that doesn’t belong
Kaluga to the one the side,
China Japan Company: Novo Nordisk Russia you can’t trust it and you should directly
Tianjin Koriyama report the shipment
Company: Novo Nordisk China Company: Novo Nordisk Japan
All NN products entering ESTONIA come via these
importers and at these ports of entry:
Importers and distributors: Port of entry:
Producers:
• Magnum Medical LTd.
• Novo Nordisk A/S
• NN France Production
• Novo Nordisk Brazil
Distributors:
• Magnum Medical OU
• TAMRO EESTI OU
• BALTFARMA OU
Products imported, distributed or with a point of entry elsewhere, are counterfeit or diverted
If you see a company that doesn’t belong to these lists, you
can’t trust it and you need to directly report the shipment
Main Batch Numbers at risk
• Batch numbers are written on the back of the packaging, below the dates
• They are important numbers for us to track our products and their origin
Currently, we observe the following batch number at risk: Batch Number
Batch do not exist with Product Frequently used Product
NN Batch numbers
NS6GG22 Rybelsus® MP5B060 Ozempic®
FT4A281 Ozempic®
NP5E775 Ozempic®
NDC7139 Norditropin®
MC74746 Norditropin®
NS6JT27 Rybelsus®
MG5B070 Ozempic®
JS7A925 Ozempic® NO6F617 Wegovy®
NPSG234 Ozempic®
9F808A Norditropin® • For Ozempic MP5B060, if its 1 mg it is a counterfeit.
• For Ozempic NP5E775, batch number does not exist for Ozempic but
If you notice a batch number from this exist for Saxenda and sold in Argentina
• For Rybelsus NS6JT27, batch number does not exist for Rybelsus but
list on a shipment, please be vigilant! exist for NovoEight intended to be sold in Colombia
Norditropin® SimpleXx® no more in
production worldwide, but still counterfeited
CF Batch numbers: FC83012, NDC7139, MC74746, 9F808A
Seen recently in Turkey and Greece
Abused by bodybuilders
Counterfeit Rybelsus example
• Rybelsus ranks as the second-most
counterfeited Novo Nordisk product
• Examine the packaging for spelling
mistakes
• The provided images highlight the
spelling discrepancies identified
Counterfeit Saxenda example
Modus operandi:
• Counterfeiters utilized Apidra SoloStar pens that resemble those of Saxenda. The pens are Sanofi's product, designed for
administering rapid-acting insulin.
• They substituted the original Apidra labels with counterfeit Saxenda labels
• They distributed Alvita needles with the pens, in place of Novo Nordisk’s own
Genuine Counterfeit
Genuine Saxenda® pen
How to differentiate:
• Dose Selector extends up to 80
on counterfeit
• Label on the pen and carton:
Fake Saxenda pen: poor quality and not adhering well
• Fake label of poor to the pen
quality
• Counterfeit needles: ALVITA
• Not adhering well
to the pen
New Modus operandi - NN genuine rapid
insulin pen relabeled as Ozempic
Counterfeit How to differentiate:
• Counterfeiters are using
Genuine NN rapid insulin pens and
relabelling them as
Ozempic
• The Ozempic® pen is
light blue with a gray
injection button, while
Fiasp® insulin pens are
Genuine Fiasp® pen
dark blue with an orange
button
Counterfeit Ozempic example
Modus operandi:
• Counterfeiters utilized Apidra SoloStar pens (1) that resemble those of Ozempic (2). The pens are Sanofi's product, designed for
administering rapid-acting insulin.
• They substituted the original Apidra labels with counterfeit Ozempic labels (3)
• They distributed Alvita needles (4) with the pens, in place of Novo Nordisk’s own
1 2
Genuine Counterfeit
3 4
How to differentiate:
• Dose Selector extends up to 80
on counterfeit
• Label on the pen and carton:
poor quality and not adhering well
to the pen
• Counterfeit needles: ALVITA
Fake Ozempic pen:
• Fake label of poor quality
• Not adhering well to the pen
Counterfeit Ozempic example
• The fake on the left has a darker blue compared to the more aqua blue
for the authentic carton. All the other letterings are a good copy.
Counterfeit Ozempic example
• The fake in left has a different SKU number compared to the original carton.
• The line of the information is misaligned compared to the original, starting from “Refrigerate ..”
Counterfeit Ozempic example
• The fake is missing a white upside • Poor printing image on the fake and
down triangle missing bold wording “day” and “weekly”.
Also missing “Lift here”
Counterfeit Ozempic example
• GTIN is incorrect and the order of the various information. The QR code
is black and white where in the legitimate carton is blue and white.
Counterfeit Ozempic example
• The fake carton was for a “1 mg” but label has “3 ml” The real does not have “3 ml”.
• The rest is all different below “For single patient use only”